🔎 Trials Near Me

Akèy › Kansè renn (Kasinom selil renn) › Pennsylvania

Etid klinik pou Kansè renn (Kasinom selil renn) nan Pennsylvania

26 etid pou Kansè renn (Kasinom selil renn) ap chèche patisipan nan sit nan Pennsylvania.

Vil nan Pennsylvania

Tèks ofisyèl etid la (Anglè)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • Research Site, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05536141

A Phase 1 Study of the Safety and Tolerability of CTX-10726

  • UPMC Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07419841

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

  • UPMC Cancer Center/Hillman Cancer Center ( Site 5017), Pittsburgh
Ap rekriteFaz 1/2
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT07049926

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Geisinger Medical Center, Danville
  • ak 7 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #104, Hershey
  • Exelixis Clinical Site #98, Philadelphia
  • Exelixis Clinical Site #32, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Pocono Medical Center, East Stroudsburg
  • ak 8 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

DESTINY-PANTUMOUR04

  • Research Site, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • UPMC-Heritage Valley Health System Beaver, Beaver
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • ak 36 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05327686

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of Pennsylvania, Philadelphia
  • WellSpan Medical Oncology & Hematology at York Cancer Center, York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

  • Penn State Cancer Institute, Hershey
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07188896

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • UPMC-Heritage Valley Health System Beaver, Beaver
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • ak 23 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06661720

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Pittsburgh
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07115043

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

  • Fox Chase Cancer Center, Philadelphia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06966024

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

  • Abramson Cancer Center at University of Pennsylvania, Philadelphia
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT05733715

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

  • Fox Chase Cancer Center, Philadelphia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07195682

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

  • Fox Chase Cancer Center, Philadelphia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT05263050

Autologous Dendritic Cell Vaccine in Kidney Cancer

  • UPMC Department of Urology, Pittsburgh
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05127824

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

  • UPMC Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06026410

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • Perelman Center for Advanced Medicine /ID# 250188, Philadelphia
  • UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT04777994

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

  • University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 28, 2026 · NCT06413680

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

  • UPMC Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT07223424

Pencil Beam Scanning in Patients With Renal Tumors

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekriteFaz 1 bonè
Laj 0 a 30 · Tout sèks · Mizajou Apr 15, 2026 · NCT03810651

A Study of VET3-TGI in Patients With Solid Tumors

  • UPMC- Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 7, 2026 · NCT06444815

Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation

  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT05641935

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

  • UPMC Altoona, Altoona
  • UPMC-Heritage Valley Health System Beaver, Beaver
  • UPMC Hillman Cancer Center at Butler Health System, Butler
  • ak 20 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT04510597

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.